Vraylar 3 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E8N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,255
Award facts
- Contract value 100% obligated
- $11,255.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,255.36 to AmerisourceBergen Drug Corp for 30-count bottles of Vraylar 3 mg capsules. This competitively awarded, firm fixed-price order was placed on January 12, 2026, with an ultimate completion date of January 13, 2026. The pharmaceutical product will be delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Vraylar is a neurological treatment medication used across military and federal healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains an extensive portfolio of pharmaceutical product deliveries across multiple therapeutic domains. This award demonstrates the contractor's continued capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F4E8N?
SPE2DR26F4E8N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4E8N worth?
The government has obligated $11,255 on SPE2DR26F4E8N.
Is contract SPE2DR26F4E8N an order under another contract?
Yes. SPE2DR26F4E8N is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E8N competed?
The extent of competition for SPE2DR26F4E8N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award